Ann Camac
Impact in
-
- Multiple Sclerosis Research Studies
-
- Neurological and metabolic disorders
Papers in
-
- Multiple Sclerosis Research Studies 6
-
- Neurological and metabolic disorders 1
- Co-authors
- Paul E. Greene (1 shared paper)A. Khandji (1 shared paper)Claudia J Chaves (3 shared papers)
- Journals
- Neurology (2 papers)The Lancet Neurology (1 paper)Movement Disorders (1 paper)Multiple Sclerosis Journal (1 paper)Neurology Clinical Practice (1 paper)
- Partner nations
- United States
In The Last Decade
Ann Camac
7 papers receiving 476 citations
Ann Camac's Hit Papers
Peers
Comparison fields: 5 of 37
- Pathology and Forensic Medicine 410
- Endocrinology, Diabetes and Metabolism 37
- Neurology 21
- Neurology 11
- Psychiatry and Mental health 15
Countries citing papers authored by Ann Camac
This map shows the geographic impact of Ann Camac's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Camac with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Camac more than expected).
Fields of papers citing papers by Ann Camac
This network shows the impact of papers produced by Ann Camac. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Camac. The network helps show where Ann Camac may publish in the future.
Co-authors
The 3 scholars most cited alongside Ann Camac, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension Hit paper breakdown → | 2018 | 286 |
| 2 | 2016 | 99 | |
| 3 | 1990 | 48 | |
| 4 | 2015 | 39 | |
| 5 | 2017 | 21 | |
| 6 | 2015 | 3 | |
| 7 | 2015 | 1 |
About Ann Camac
Ann Camac is a scholar working on Pathology and Forensic Medicine, Endocrinology, Diabetes and Metabolism, Nuclear Energy and Engineering, Waste Management and Disposal and Infectious Diseases, having authored 7 papers that have together received 497 indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (6 papers) and Neurological and metabolic disorders (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (410 citations), Endocrinology, Diabetes and Metabolism (37 citations), Neurology (21 citations), Neurology (11 citations) and Psychiatry and Mental health (15 citations). Ann Camac has collaborated with scholars based in United States. Frequent co-authors include Paul E. Greene, A. Khandji and Claudia J Chaves. Their work appears in journals such as Neurology, The Lancet Neurology, Movement Disorders, Multiple Sclerosis Journal and Neurology Clinical Practice.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.